المؤلفون: Sankar K; Cedars-Sinai Medical Center, Los Angeles, CA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA.; Fred Hutchinson Cancer Center, Seattle, WA., Dragnev KH; Dartmouth Hitchcock Medical Center, Lebanon, NH., Henick BS; Columbia University/Herbert Irving Comprehensive Cancer Center, New York, NY., Iams WT; Vanderbilt University Medical Center, Nashville, TN., Blanke CD; SWOG Network Operations Center/Oregon Health & Science University, Portland, OR., Herbst RS; Yale University, New Haven, CT., Gray JE; Moffitt Cancer Center, Tampa, FL., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, CA.

المصدر: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2024 Jun; Vol. 44 (3), pp. e100040.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Clinical Trials as Topic*, Humans ; Research Design ; Pragmatic Clinical Trials as Topic/methods ; Medical Oncology/methods

المؤلفون: Weaver AN; University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA., Iams WT; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Park JC; Massachusetts General Hospital, Boston, Massachusetts, USA., Mita M; Cedars-Sinai Medical Center, Los Angeles, California, USA., Holtick U; Department of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, North Rhine-Westphalia, Germany., Gordon MS; Pinnacle Oncology Hematology, Arizona Center for Cancer Care, HonorHealth Research Institute Clinical Trials Program, Virginia G. Piper Cancer Center, Scottsdale, Arizona, USA., Rodabaugh KJ; University of Nebraska Medical Center, Omaha, Nebraska, USA., Dhani N; University Health Network Princess Margaret Cancer Centre, Toronto, Canada., Neupane P; University of Kansas Cancer Center, Fairway, Kansas, USA., Taylor M; Earle A. Chiles Research Institute, Portland, Oregon, USA., Amanda Duvall E; SQZ Biotechnologies, Watertown, Massachusetts, USA., Jennings J; SQZ Biotechnologies, Watertown, Massachusetts, USA., Miselis NR; SQZ Biotechnologies, Watertown, Massachusetts, USA., Loughhead S; SQZ Biotechnologies, Watertown, Massachusetts, USA., Warren MS; SQZ Biotechnologies, Watertown, Massachusetts, USA., Bernstein H; SQZ Biotechnologies, Watertown, Massachusetts, USA., Klussmann JP; Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, North Rhine-Westphalia, Germany., Baranda J; University of Kansas Cancer Center, Fairway, Kansas, USA., Jimeno A; University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2024 Aug; Vol. 63 (8), pp. 1421-1428. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/immunology , Human papillomavirus 16*/immunology , Papillomavirus Infections*/complications , Papillomavirus Infections*/immunology , Papillomavirus Infections*/virology, Humans ; Female ; Middle Aged ; Male ; Papillomavirus E7 Proteins/immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Aged ; Oncogene Proteins, Viral/immunology ; Cancer Vaccines/therapeutic use ; Cancer Vaccines/administration & dosage ; Cancer Vaccines/immunology ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/mortality ; Adult ; Leukocytes, Mononuclear/immunology ; Repressor Proteins

المؤلفون: Perez B; Moffitt Cancer Center, Tampa., Aljumaily R; Stephenson Cancer Center, Oklahoma City., Marron TU; Icahn School of Medicine at Mount Sinai, New York., Shafique MR; Moffitt Cancer Center, Tampa., Burris H; Sarah Cannon Research Institute, Nashville., Iams WT; Vanderbilt University Medical Center, Nashville., Chmura SJ; University of Chicago Medicine, Chicago., Luke JJ; UPMC Hillman Cancer Center, Pittsburgh., Edenfield W; Greenville Health System, Institute for Translational Oncology Research, Greenville., Sohal D; University of Cincinnati Medical Center, Cincinnati, USA., Liao X; Merck Serono Co., Ltd. (An Affiliate of Merck KGaA), Beijing, China., Boesler C; Merck Healthcare KGaA, Darmstadt, Germany., Machl A; EMD Serono Research & Development Institute, Inc. (An Affiliate of Merck KGaA), Billerica, USA., Seebeck J; Merck Healthcare KGaA, Darmstadt, Germany., Becker A; Merck Healthcare KGaA, Darmstadt, Germany., Guenther B; Merck Healthcare KGaA, Darmstadt, Germany., Rodriguez-Gutierrez A; Merck, S.L.U. (An Affiliate of Merck KGaA), Madrid, Spain., Antonia SJ; Duke Cancer Institute, Durham, USA. Electronic address: scott.antonia@duke.edu.

المصدر: ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102217. Date of Electronic Publication: 2024 Feb 05.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/radiotherapy , Pyridazines*, Humans ; Antibodies, Monoclonal, Humanized/pharmacology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Quinazolines/therapeutic use

المؤلفون: Patil T; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Staley A; University of Colorado Cancer Center Biostatistics Core, University of Colorado School of Medicine, Aurora, Colorado., Nie Y; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut., Sakamoto M; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Stalker M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Jurica JM; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Koehler K; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Cass A; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Kuykendall H; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Schmitt E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Filar E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Reventaite E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Davies KD; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Nijmeh H; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Haag M; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Yoder BA; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Bunn PA; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Schenk EL; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Aisner DL; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Iams WT; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Camidge DR; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.

المصدر: JTO clinical and research reports [JTO Clin Res Rep] 2024 Jan 18; Vol. 5 (2), pp. 100637. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

المؤلفون: Bhatia S; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Cortez MG; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Lessans S; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Iams WT; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

المصدر: Oncotarget [Oncotarget] 2024 Jan 16; Vol. 15, pp. 27-30. Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/chemically induced , Acrylamides* , Indoles* , Pyrimidines*, Female ; Humans ; Protein Kinase Inhibitors ; ErbB Receptors/genetics ; Aniline Compounds ; Mutation

المؤلفون: Iams WT; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Mackay M; Tempus Labs Inc, Chicago, Illinois., Ben-Shachar R; Tempus Labs Inc, Chicago, Illinois., Drews J; Tempus Labs Inc, Chicago, Illinois., Manghnani K; Tempus Labs Inc, Chicago, Illinois., Hockenberry AJ; Tempus Labs Inc, Chicago, Illinois., Cristofanilli M; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, New York.; NewYork-Presbyterian Hospital, New York, New York., Nimeiri H; Tempus Labs Inc, Chicago, Illinois., Guinney J; Tempus Labs Inc, Chicago, Illinois., Benson AB 3rd; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

المصدر: JAMA network open [JAMA Netw Open] 2024 Jan 02; Vol. 7 (1), pp. e2351700. Date of Electronic Publication: 2024 Jan 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/genetics , Carcinoma, Non-Small-Cell Lung* , Lung Neoplasms* , Breast Neoplasms*, Male ; Humans ; Female ; Cohort Studies ; Mutation

المؤلفون: Iams WT; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Ave, 780 PRB, Nashville, TN, 37232, USA. wade.t.iams@vumc.org., Konduri K; Baylor Charles A. Sammons Cancer Center, Texas Oncology PA, Dallas, TX, USA.

المصدر: Advances in therapy [Adv Ther] 2023 Dec; Vol. 40 (12), pp. 5567-5578. Date of Electronic Publication: 2023 Oct 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Webcast

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/diagnosis , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Oncologists*, Humans ; Biomarkers, Tumor/genetics ; Medical Oncology ; Mutation

المؤلفون: Lander EM; 1Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Li X; 1Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Huang LC; 2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Cass AS; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Iams WT; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Skotte EA; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Whisenant JG; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Ramirez RA; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., York SJ; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Osterman TJ; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Lewis JA; 1Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.; 4Veterans Health Administration-Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC) and Medicine Services, Nashville, Tennessee.; 5Center for Clinical Quality and Implementation Research, Vanderbilt University Medical Center, Nashville, Tennessee., Lovly CM; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Shyr Y; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Horn L; 3Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Oct; Vol. 21 (10), pp. 1050-1057.e13.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/epidemiology , Lung Neoplasms*/therapy, Humans ; Middle Aged ; Aged ; Retrospective Studies ; Hospitalization ; Palliative Care ; Hospitals

المؤلفون: Paez R; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN., Kammer MN; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN., Tanner NT; Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC., Shojaee S; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN., Heideman BE; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN., Peikert T; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN., Balbach ML; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Iams WT; Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt-Ingram Cancer Center, Nashville, TN., Ning B; Department of Medicine, Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA., Lenburg ME; Department of Medicine, Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA., Mallow C; Division of Pulmonary, Critical Care and Sleep Medicine, University of Miami, Miami, FL., Yarmus L; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD., Fong KM; University of Queensland Thoracic Research Centre, The Prince Charles Hospital, Brisbane, QLD, Australia., Deppen S; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt-Ingram Cancer Center, Nashville, TN; Tennessee Valley Healthcare System, Nashville, TN., Grogan EL; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt-Ingram Cancer Center, Nashville, TN; Tennessee Valley Healthcare System, Nashville, TN., Maldonado F; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address: fabien.maldonado@vumc.org.

المصدر: Chest [Chest] 2023 Oct; Vol. 164 (4), pp. 1028-1041. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Pulmonary Nodules*/diagnosis , Lung Neoplasms*/pathology, Humans ; Biomarkers ; Tomography, X-Ray Computed/methods ; Blood Proteins

المؤلفون: He K; Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, Ohio. Electronic address: kai.he@osumc.edu., Berz D; Department of Cellular Therapeutics, Beverly Hills Cancer Center, Beverly Hills, California; Current Affiliation: Valkyrie Clinical Trials, Los Angeles, California., Gadgeel SM; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan., Iams WT; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Bruno DS; University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Blakely CM; Department of Medicine, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Spira AI; Virginia Cancer Specialists, Fairfax, Virginia; US Oncology Network, The Woodlands, Texas., Patel MR; Division Of Hematology, Oncology and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota., Waterhouse DM; US Oncology Network, The Woodlands, Texas; Department of Clinical Research, Oncology Hematology Care, Cincinnati, Ohio; Current affiliation: Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford, Massachusetts., Richards DA; US Oncology Network, The Woodlands, Texas; Texas Oncology, Tyler, Texas., Pham A; Northwest Cancer Specialists, Tigard, Oregon., Jotte R; US Oncology Network, The Woodlands, Texas; Rocky Mountain Cancer Centers, Denver, Colorado., Hong DS; MD Anderson Cancer Center, The University of Texas, Houston, Texas., Garon EB; Department Of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California; Winship Cancer Institute, Emory University, Atlanta, Georgia., Traynor A; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Olson P; Mirati Therapeutics, Inc., San Diego, California., Latven L; Mirati Therapeutics, Inc., San Diego, California., Yan X; Mirati Therapeutics, Inc., San Diego, California., Shazer R; Mirati Therapeutics, Inc., San Diego, California., Leal TA; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; Current Affiliation: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jul; Vol. 18 (7), pp. 907-921. Date of Electronic Publication: 2023 Feb 24.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology, Humans ; Nivolumab/pharmacology ; Nivolumab/therapeutic use ; Anilides/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Tumor Microenvironment